Dr. Walmik Gaikwad | Conjugate Vaccines | Breakthrough Research Award

Dr. Walmik Gaikwad | Conjugate Vaccines | Breakthrough Research Award

Inventprise Inc. Redmond, WA, US | United States

Dr. Walmik Gaikwad is a skilled biotechnologist and manufacturing leader with more than two decades of experience spanning academic research, industrial R&D, and large-scale vaccine production. He holds a Ph.D. in Chemical and Biotechnology from Savitribai Phule Pune University, where his doctoral work focused on developing conjugation processes for Streptococcus pneumoniae capsular polysaccharides with carrier proteins. He earned his M.Tech. in Biotechnology from Padmashree Dr. D. Y. Patil Institute for Biotechnology and Bioinformatics, specializing in bioremediation of phenolic compounds, and his B.Tech. in Chemical–Pharmaceutical and Fine Chemicals from Dr. Babasaheb Ambedkar Marathwada University, where he explored the synthesis of chromenone derivatives. Professionally, Dr. Gaikwad has led projects across upstream, downstream, and conjugation process development with extensive expertise in cGMP and GLP environments. His career includes key roles at Inventprise Inc., Redmond, where he currently manages vaccine manufacturing operations, and the Serum Institute of India, where he contributed significantly to multivalent conjugate vaccine R&D and production, regulatory audits, and technology transfer. His research interests lie in vaccine development, process optimization, and bioprocess scale-up under stringent quality frameworks. Recognized for his strategic leadership, regulatory acumen, and scientific rigor, Dr. Gaikwad continues to advance innovation in global vaccine manufacturing.

Profile: Google Scholar

Featured Publications

Simultaneous purification and depolymerization of Streptococcus pneumoniae serotype 2 capsular polysaccharides by trifluoroacetic acid

Purification of capsular polysaccharides isolated from S. pneumoniae serotype 2 by hydrogen peroxide and endonuclease

Effect of trifluoroacetic acid on the antigenicity of capsular polysaccharides obtained from various Streptococcus pneumoniae serotypes

Partial depolymerization of capsular polysaccharides isolated from Streptococcus pneumoniae serotype 2 by various methods

Methods for simultaneous fragmentation and purification of bacterial polysaccharides

Method for obtaining purified bacterial polysaccharides